About Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome
Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome is a rare disease catalogued by Orphanet (ORPHA:391376). It is associated with the ASNS gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome trials.
Search ClinicalTrials.gov for "Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome" or filter by Orphanet code ORPHA:391376 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome. Updated daily.